Experts from the American health authority recommended Friday the resumption of vaccination with Johnson & Johnson's serum in the United States, suspended since April 13 after rare cases of thrombosis.
Read also: Europe's green light for Johnson & Johnson vaccine
The vaccine
"is recommended"
for the adult population, concluded Friday a group assembled at the request of the American Centers for Disease Control and Prevention (CDC), the principal American agency of public health.
The CDC Director will make the final decision.
Health authorities had announced a pause in the use of the vaccine developed by the American laboratory to investigate several cases of women who developed severe cases of blood clots in association with low levels of platelets after their injection.